These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 1413928

  • 21. [Screening for increased cholesterol values in blood donors].
    Dengler T, Kasulke D, Oehmig R, Kellner S, Fürst G.
    Infusionsther Transfusionsmed; 1995 Aug; 22(4):226-31. PubMed ID: 7496121
    [Abstract] [Full Text] [Related]

  • 22. Indianapolis cholesterol screening 1987: does mass screening accomplish its goal?
    Miller JZ, Statland BE, Roger B, Suther C, Furst JL, Fineberg NS.
    Indiana Med; 1989 Jul; 82(7):526-31. PubMed ID: 2754243
    [Abstract] [Full Text] [Related]

  • 23. [The 1990 Bochum cholesterol and blood screening program. Incidence and degree of treatment of cardiovascular risk factors].
    Spelsberg A, Weiland K, Stolpe S, Segerling M, Keil U.
    Fortschr Med; 1992 Jul 30; 110(21):387-92. PubMed ID: 1516875
    [Abstract] [Full Text] [Related]

  • 24. Lipid levels. Applying the second National Cholesterol Education Program report to geriatric medicine.
    Mormando RM.
    Geriatrics; 2000 Aug 30; 55(8):48-53; quiz 54. PubMed ID: 10953686
    [Abstract] [Full Text] [Related]

  • 25. [Risk factors of atherosclerosis--primary examination of Vienna employees].
    Stelzeneder M, Harmuth P, Weiss K, Katzenschlager R, Richter H, Widhalm K, Sinzinger H.
    Wien Klin Wochenschr; 1992 Aug 30; 104(17):526-30. PubMed ID: 1413812
    [Abstract] [Full Text] [Related]

  • 26. [Risk factors of atherosclerosis: results of screening in Southern Austria].
    Weiss K, Katzenschlager R, Egert H, Cajka P, Sinzinger H.
    Wien Klin Wochenschr; 1991 Aug 30; 103(18):566-70. PubMed ID: 1750224
    [Abstract] [Full Text] [Related]

  • 27. Community screening for hypercholesterolemia.
    Bell MM, Joseph S.
    J Fam Pract; 1990 Oct 30; 31(4):365-8. PubMed ID: 2212966
    [Abstract] [Full Text] [Related]

  • 28. [Revision of consensus cholesterol].
    Erkelens DW.
    Ned Tijdschr Geneeskd; 1991 Dec 07; 135(49):2337-40. PubMed ID: 1809892
    [Abstract] [Full Text] [Related]

  • 29. Addressing unanswered questions about population cholesterol screenings: the Model Systems for Blood Cholesterol Screening Program.
    Havas S, Greenland P, Wones R, Schucker B.
    Am J Prev Med; 1989 Dec 07; 5(6):337-46. PubMed ID: 2597429
    [Abstract] [Full Text] [Related]

  • 30. [Report on cholesterol levels of Spanish children and adolescents. Group of Experts of Spanish Societies of Arteriosclerosis, Cardiology, Pediatrics, Nutrition and Preventive Medicine].
    Plaza Pérez I.
    Rev Esp Cardiol; 1991 Nov 07; 44(9):567-85. PubMed ID: 1775703
    [Abstract] [Full Text] [Related]

  • 31. Trends in plasma cholesterol levels in the atherosclerosis risk in communities (ARIC) study.
    Szklo M, Chambless LE, Folsom AR, Gotto A, Nieto FJ, Patsch W, Shimakawa T, Sorlie P, Wijnberg L.
    Prev Med; 2000 Mar 07; 30(3):252-9. PubMed ID: 10684749
    [Abstract] [Full Text] [Related]

  • 32. [Cholesterol and triglyceride levels and their development from 2 to 17 years of age].
    Samánek M, Urbanová Z.
    Cas Lek Cesk; 1997 Jun 12; 136(12):380-5. PubMed ID: 9333510
    [Abstract] [Full Text] [Related]

  • 33. [Measurement of cholesterol in capillary blood using the Reflotron system. Results from approximately 1,000 comparisons with reference measurements of cholesterol in venous serum].
    Gerdes LU, Bak AM, Faergeman O.
    Ugeskr Laeger; 1990 Jun 11; 152(24):1739-43. PubMed ID: 2360292
    [Abstract] [Full Text] [Related]

  • 34. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
    Wilt TJ, Rubins HB, Collins D, O'Connor TZ, Rutan GH, Robins SJ.
    Arch Intern Med; 1996 Jun 10; 156(11):1181-8. PubMed ID: 8639012
    [Abstract] [Full Text] [Related]

  • 35. Reflotron performance in a community screening program: results of the Massachusetts Model Systems for Blood Cholesterol Screening Project.
    Havas S, Bishop R, Koumjian L, Reisman J, Wozenski S.
    Am J Prev Med; 1991 Jun 10; 7(6):397-405. PubMed ID: 1790049
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Risk status of screened population based on elevated serum cholesterol values].
    Weitgasser R.
    Acta Med Austriaca Suppl; 2002 Jun 10; 56():14-6. PubMed ID: 12436707
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Worksite screening for high blood cholesterol: implications for detection, evaluation and treatment--the Israel CORDIS Study.
    Green MS, Jucha E, Peled I.
    Isr J Med Sci; 1992 Jul 10; 28(7):406-17. PubMed ID: 1506163
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.